Solid Biosciences Inc (SLDB)
10.00
-0.10
(-0.94%)
USD |
NASDAQ |
May 06, 16:00
10.00
0.00 (0.00%)
After-Hours: 16:09
Solid Biosciences Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2022 | 14.78M |
March 31, 2022 | 12.21M |
Date | Value |
---|---|
December 31, 2021 | 13.62M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
12.21M
Minimum
Mar 2022
14.78M
Maximum
Jun 2022
13.54M
Average
13.62M
Median
Dec 2021
Revenue (TTM) Benchmarks
Sarepta Therapeutics Inc | 1.403B |
PTC Therapeutics Inc | 927.56M |
Capricor Therapeutics Inc | 25.18M |
Perspective Therapeutics Inc | 0.00 |
Electromed Inc | 51.69M |